Healthy and Successful Longevity Grand Challenge

Singapore's RIE2030 Grand Challenge on Maximising Healthy and Successful Longevity is a national research and translation programme for helping people live longer in better health while managing the pressures of ageing and healthcare costs. MOH stated on 22 May 2026 that NRF, in partnership with MOH, would launch the Grand Challenge and that the Government had committed S$350 million under RIE2030 (MOH, 22 May 2026). The commitment supports coordinated research, public-private collaborations and translation into evidence-based interventions. It is not a cash benefit for older residents, an insurance scheme, or a replacement for Age Well SG services: it is not Age Well SG.

Research challenge and national coordination

The Grand Challenge uses a mission-oriented model: instead of funding only disconnected bottom-up projects, it is intended to identify critical scientific and practical gaps, coordinate a portfolio of research, and create pathways for testing and implementing useful interventions. NRF supplies the national RIE leadership and MOH brings the health-policy and care-system context (MOH, 22 May 2026). The programme is framed around healthy longevity rather than lifespan alone: its objective is to delay or reduce age-related decline and support people to remain healthy, functional and independent. A research proposal, technology or company therefore needs a relevant use case and collaboration pathway; the existence of a national challenge does not itself approve every product or application.

Brain Health and Physical Function

MOH identifies Brain Health and Physical Function as key priorities. Brain-health work may address the biology and progression of age-related cognitive decline, including vascular dementia, with the aim of developing better tests or interventions. Physical-function work includes conditions such as sarcopenic obesity, where muscle loss and fat accumulation together increase frailty risk (MOH, 22 May 2026). The two priorities are therefore programme-level research directions that can span prevention, measurement, treatment and functional support, rather than a single clinical intervention or beneficiary category. These priorities are research themes, not diagnoses or clinical entitlements. A mention of vascular dementia or sarcopenic obesity in the Grand Challenge does not establish a universal screening programme, treatment recommendation or reimbursement rule; those questions require current clinical guidance and service-specific information.

Socio-environmental innovation and public-private collaborations

The Grand Challenge extends beyond biomedical research. MOH describes Socio-Environmental Innovations as a workstream for optimising the built environment, social systems and digital-health technologies to support healthy longevity (MOH, 22 May 2026). In July 2026, the Health Minister said the Grand Challenge would develop AI use cases that could nudge healthier behaviour and support seniors to live safely and independently, with companies encouraged to work with public healthcare institutions and Singapore's anonymised data resources (MOH, 25 July 2026). Such collaboration still requires the applicable privacy, ethics, clinical-safety, procurement and regulatory controls. A public-private proposal is a route to consideration, not a guarantee of funding or deployment.

Funding period and relationship to existing ageing programmes

The S$350 million commitment is recorded for the RIE2030 plan period from April 2026 through 2030; it is an initiative-level allocation for research and translation, not a household or senior-support budget. Existing programmes have different roles. Eldercare explains home, centre-based, residential and caregiver services; Age Well SG supports ageing actively in homes and communities; and healthcare financing explains subsidies and the 3Ms. The Grand Challenge is the research-and-innovation layer that may produce new evidence, technologies or service models for healthy ageing. Current calls, participating institutions, eligibility and implementation details should be taken from the live NRF/MOH notice rather than inferred from the headline allocation or from the existence of Age Well SG (MOH, 22 May 2026).